FDA's New Drug Chief Resigns Weeks After Appointment
TL;DR Summary
Richard Pazdur, the top drug regulator at the FDA, resigned just three weeks after taking the role amid disagreements over agency overhaul plans and concerns about transparency and legality, highlighting ongoing turmoil within the agency.
- More FDA drama: Top drug regulator calls it quits after 3 weeks Ars Technica
- Top FDA drug regulator plans to depart weeks into job The Washington Post
- The FDA’s top drug regulator submits his resignation to the agency Politico
- Pazdur to retire weeks after assuming leadership of CDER FirstWord Pharma
- US FDA's newly appointed drugs chief set to retire Reuters
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
1 min
vs 2 min read
Condensed
87%
261 → 35 words
Want the full story? Read the original article
Read on Ars Technica